SPONSOR
University Hospital Tuebingen
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 1, Phase 1, Phase 2, Phase 3
Conditions studied: Major Depressive DisorderProstate CancerLeptomeningeal DiseaseHematologic MalignancyOffspring Exposed to GDM and ControlCongenital Heart Disease (CHD)PARKINSON DISEASE (Disorder)MelanomaSpitzoid MelanomaCongenital Nevi
University Hospital Tuebingen is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Major Depressive Disorder, Prostate Cancer, Leptomeningeal Disease, Hematologic Malignancy.
The trial portfolio spans Phase 2, Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital Tuebingen
How many clinical trials has University Hospital Tuebingen sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by University Hospital Tuebingen, of which 8 are actively recruiting participants. These trials cover conditions including Major Depressive Disorder, Prostate Cancer, Leptomeningeal Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital Tuebingen research focus on?
University Hospital Tuebingen clinical trials span Major Depressive Disorder, Prostate Cancer, Leptomeningeal Disease, Hematologic Malignancy, Offspring Exposed to GDM and Control, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital Tuebingen clinical trial?
To participate in a University Hospital Tuebingen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital Tuebingen trials with current recruitment status updated daily.
Clinical Trials by University Hospital Tuebingen
NCT06410599 Phase 2
Recruiting
Pharmacologic Treatment Augmentation in Chronic Depression
Major Depressive Disorder
NCT02724670
Recruiting
Study of MR-based IGRT for Prostate Cancer
Prostate Cancer
NCT05112549 Phase 1
Recruiting
Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
Leptomeningeal Disease
NCT05943067 Phase 1, Phase 2
Recruiting
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Hematologic Malignancy
NCT04722900
Recruiting
PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes
Offspring Exposed to GDM and Control
NCT06845371
Recruiting
MELODY Registry Follow-Up Study
Congenital Heart Disease (CHD)
NCT07151378 Phase 3
Recruiting
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
PARKINSON DISEASE (Disorder)
NCT06680323
Recruiting
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
Melanoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology